Skip to main content
AKI India Limited logo

AKI India Limited — Investor Relations & Filings

Ticker · AKI ISIN · INE642Z01026 LEI · 254900SJK6H1BPOCMR17 BSE.NS Manufacturing
Filings indexed 194 across all filing types
Latest filing 2025-11-13 Regulatory Filings
Country IN India
Listing BSE.NS AKI

About AKI India Limited

https://www.groupaki.com/

AKI India Limited specializes in the production and export of high-quality leather and leather-based products. The company's core operations encompass the entire value chain, from the processing of raw hides into finished leather to the manufacturing of value-added goods. Its diverse product portfolio includes footwear, bags, belts, and specialized equestrian equipment such as saddlery and harnesses. Utilizing advanced tanning and manufacturing technologies, the firm caters to a global clientele across various international markets. The company emphasizes quality assurance and technical precision in its manufacturing processes to meet the rigorous standards of the global fashion and utility sectors.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing about the rescheduling of a Board Meeting. It references the agenda to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended 30th September 2025 along with a limited review report. The document is short (2121 characters) and serves as an announcement of the meeting and its agenda, not the actual financial results or report itself. It is a regulatory announcement related to board meeting scheduling and financial results approval, but does not contain substantive financial data or the results themselves. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and notification to exchanges.
2025-11-13 English
Outcome of Board Meeting
Regulatory Filings Classification · 95% confidence The document is a letter from AKI India Limited addressed to stock exchanges informing about the rescheduling of a Board Meeting. It references the agenda to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended 30th September 2025 along with a limited review report. The document does not contain the financial results themselves but is an announcement about the timing and agenda of a board meeting. The document length is short (2121 characters) and it is primarily an announcement rather than a report. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement about board meeting scheduling and agenda, not the actual Interim/Quarterly Report or Earnings Release.
2025-11-13 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-11-10 English
Board Meeting — Financial Results/Other business matters
Regulatory Filings Classification · 95% confidence The document is a formal letter from AKI India Limited addressed to stock exchanges (BSE and NSE) informing about an upcoming Board Meeting scheduled for 13th November 2025. The letter specifically mentions that the Board will consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended 30th September 2025, along with a limited review report. This is a notice of a board meeting to approve interim financial results, not the results themselves. The document is short (2037 characters) and serves as an intimation or announcement rather than containing actual financial data or detailed reports. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2025-11-10 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a submission of a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 30th September 2025. It is a confirmation certificate from the Registrar and Share Transfer Agent regarding dematerialisation of securities and related compliance. The document is short (3750 characters) and serves as a regulatory compliance certificate rather than a financial report or detailed filing. It does not contain financial statements or detailed analysis but is a regulatory filing confirming compliance with SEBI regulations. Therefore, it fits best under Regulatory Filings (RNS).
2025-10-10 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) informing about the closure of the trading window for insiders due to upcoming unaudited financial results for the quarter and half year ended 30th September 2025. It references regulatory compliance with SEBI (Prohibition of Insider Trading) Regulations and the company's internal code. The document does not contain any financial data, results, or detailed report content but is an announcement related to trading restrictions ahead of financial results publication. The document length is short (1614 characters), and it serves as a regulatory notification rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance notice.
2025-09-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.